Literature DB >> 8457259

Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites.

M I Kamboh1, C E Aston, R E Ferrell, R F Hamman.   

Abstract

The extent of apolipoprotein E (apo E) polymorphism and its effect on eight quantitative risk factors for coronary heart disease (total cholesterol; low density lipoprotein (LDL) cholesterol; total high density lipoprotein and its subfractions, HDL2 and HDL3; triglycerides; fasting glucose and fasting insulin) has been determined in 238 randomly selected Hispanics (120 males and 118 females) and 201 non-Hispanic whites (NHWs) (105 males and 96 females) from the San Luis Valley, Colorado. The frequencies for the E * 2, E * 3 and E * 4 alleles were 0.048, 0.853 and 0.099, respectively, in Hispanics and 0.080, 0.783 and 0.137, respectively, in NHWs. Relatively low frequency of the E * 2 and E * 4 alleles in Hispanics compared with NHWs is consistent with the genetic and anthropologic data that Hispanics have substantial Amerindian admixture. The impact of apo E polymorphism on each quantitative trait was estimated after adjusting for concomitant variables including age, cigarette smoking and body mass index in both genders and pre- or post-menopause status in females. The distribution of eight quantitative traits was analyzed among three common apo E phenotypes, 3-2, 3-3 and 4-3. In Hispanics, significant variability among apo E phenotypes was observed for total cholesterol (P = 0.001) in females only and the apo E polymorphism accounts for 12.4% variation in total cholesterol and 15.2% variation in LDL-cholesterol. In NHWs, significant mean differences among apo E phenotypes were observed for total cholesterol in both males (P = 0.007) and females (P = 0.0004). In NHW males and females, the apo E polymorphism explained 9.2% and 12.4%, respectively, of the variation in total cholesterol, and 15.1% and 6.6%, respectively, of the variation in LDL-cholesterol. In NHWs, borderline significance levels were also noted for phenotype specific differences in HDL2-cholesterol in males (P = 0.04) and females (P = 0.05), for total HDL cholesterol in females (P = 0.02) and HDL3-cholesterol in females (P = 0.06). While the estimated effects of the apo E polymorphism on quantitative traits differ somewhat between Hispanics and non-Hispanic whites, this probably reflects the overall difference in frequencies of the less common alleles in the Hispanics rather than a biological difference in the effects of these alleles on lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457259     DOI: 10.1016/0021-9150(93)90129-i

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  11 in total

1.  Effect of apolipoprotein E gene Hha I restricting fragment length polymorphism on serum lipids in cholecystolithiasis.

Authors:  Qi-Yuan Lin; Jing-Ping Du; Ming-Yi Zhang; Yu-Gwei Yao; Lin Li; Nan-Sheng Cheng; Lu-Nan Yan; Lu-Jia Xiao
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

Review 2.  Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence.

Authors:  Yu Yamazaki; Meghan M Painter; Guojun Bu; Takahisa Kanekiyo
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

3.  Apolipoprotein E polymorphism in Northern Indian patients with coronary heart disease: phenotype distribution and relation to serum lipids and lipoproteins.

Authors:  Kalpana Luthra; Balram Bharghav; Shivani Chabbra; Nibhriti Das; Anoop Misra; Dharam P Agarwal; Ravindra M Pandey; L M Srivastava
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

Review 4.  Pharmacogenetics of Lipid-lowering Therapies.

Authors:  Jose M Ordovas; Haiqing Shen
Journal:  Curr Atheroscler Rep       Date:  2002-05       Impact factor: 5.113

5.  APOE genotype affects black-white responses of high-density lipoprotein cholesterol subspecies to aerobic exercise training.

Authors:  Thomas O Obisesan; Robert E Ferrell; Andrew P Goldberg; Dana A Phares; Tina J Ellis; James M Hagberg
Journal:  Metabolism       Date:  2008-12       Impact factor: 8.694

6.  ApoE polymorphism in a small Mediterranean island: relationships with plasma lipids, lipoproteins and LDL particle size.

Authors:  C M Barbagallo; F Polizzi; M Severino; M Rizzo; N Vivona; F Onorato; R Caldarella; A B Cefalù; D Noto; A Notarbartolo; M R Averna
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

7.  Gender- and age-specific contributions of additional DNA sequence variation in the 5' regulatory region of the APOE gene to prediction of measures of lipid metabolism.

Authors:  Ruth Frikke-Schmidt; Charles F Sing; Børge G Nordestgaard; Anne Tybjaerg-Hansen
Journal:  Hum Genet       Date:  2004-09       Impact factor: 4.132

8.  Neuroprotection and neurodegeneration in Alzheimer's disease: role of cardiovascular disease risk factors, implications for dementia rates, and prevention with aerobic exercise in african americans.

Authors:  Thomas O Obisesan; Richard F Gillum; Stephanie Johnson; Nisser Umar; Deborah Williams; Vernon Bond; John Kwagyan
Journal:  Int J Alzheimers Dis       Date:  2012-04-17

9.  ApoE (Apolipoprotein E) in Brain Pericytes Regulates Endothelial Function in an Isoform-Dependent Manner by Modulating Basement Membrane Components.

Authors:  Yu Yamazaki; Mitsuru Shinohara; Akari Yamazaki; Yingxue Ren; Yan W Asmann; Takahisa Kanekiyo; Guojun Bu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-10-31       Impact factor: 10.514

10.  Apolipoprotein E epsilon 2 allele and low serum cholesterol as risk factors for gastric cancer in a Chinese Han population.

Authors:  Ranran Kang; Ping Li; Tingting Wang; Xinxiu Li; Zichen Wei; Zhenlian Zhang; Li Zhong; Longlong Cao; Michael G Heckman; Yun-Wu Zhang; Huaxi Xu; Changming Huang; Guojun Bu; Xiao-Fen Chen
Journal:  Sci Rep       Date:  2016-01-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.